Tracking tumor-specific CD8<sup>+</sup> T cell responses.

Burke, Kelly P; Markson, Samuel C; Sharpe, Arlene H

Tracking tumor-specific CD8⁺ T cell responses.

Burke, Kelly P; Markson, Samuel C; Sharpe, Arlene H.

Affiliation

Burke KP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Markson SC; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Evergrande Center for Immunological Diseases, Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA. Electronic address: Arlene_Sharpe@hms.harvard.edu.

Trends Immunol ; 44(5): 326-328, 2023 05.

Article in En | MEDLINE | ID: mdl-37031062

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Melanoma Limits: Humans Language: En Journal: Trends Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google